Global Neurofibromatosis Treatment Market to Receive Impetus from New Drugs Under Clinical Trials

Albany, NY -- (SBWire) -- 06/09/2016 --The growing count of drugs in clinical trials, poised to emerge as breakthrough treatment options for neurofibromatosis, are amongst the key factors fuelling the growth of the neurofibromatosis treatment market. A new market research report by Transparency Market Research, titled "Neurofibromatosis Treatment Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast 2015 – 2023,"offers extensive information on the condition and studies the market on the basis of both volume as well as revenue.

The key dynamics impacting the growth of the market for neurofibromatosis treatment have also been highlighted under this study. A detailed analysis of the factors governing the market's growth in key regions and the most defining market trends forms an important part of this study. All the segments within the market have been studied on the basis of their market attractiveness and the key developments taking place in the market have also been detailed.

Neurofibromatosis refers to numerous genetically inherited conditions that differ genetically and clinically and have a huge possibility of tumor formation. These tumors may form anywhere within the nervous system of the patient including the spinal cord, nerves, or brain. In the majority of cases, these tumors are non-cancerous; however, in some cases, these tumors may become malignant. There are mild symptoms reported by the patients suffering from neurofibromatosis. These may include learning impairment, hearing loss, severe pain, and loss of vision. As of now, there is no proven treatment for curing neurofibromatosis; however, there are treatments for managing the complications associated with this condition.

Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7156

Neurofibromatosis is of three main types, namely, neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. Amongst these, neurofibromatosis type 1 (NF1) is the most common type, whereas schwannomatosis has been recently identified and is a rare type of neurofibromatosis.

By treatment, the market is segmented into surgery, drug therapy,chemotherapy, and radiation therapy. Amongst these, surgery is the most commonly utilized option for removing tumors.Surgery is also utilized in the treatment for retinal abnormalities and cataracts in the patients suffering from neurofibromatosis. However, surgeries may cause hearing impairment in patients. On the other hand, treatments such as chemotherapy and radiation therapy have also been utilized extensively in the market.

Although, at present there are no drugs within the market, still there are certain drugs in phase III of the clinical trials. These are Tamsulosin HCL (GL Pharm Tech Corporation) and Lamotrigine (Erasmus Medical Center).On the other hand, the drugs in phase II of the clinical trials are RAD001 (Assistance Publique - Hôpitaux de Paris), Cabozantinib (University of Alabama at Birmingham), Everolimus (Texas Neurofibromatosis Foundation), Gleevec (Indiana University), and others.

By geography, neurofibromatosis has a low prevalence rate and is an orphan disease. The key institutes and organizationstaking efforts for the treatment of neurofibromatosis are GL Pharm Tech Corporation,Erasmus Medical Center, University of Alabama at Birmingham, Texas Neurofibromatosis Foundation, Indiana University, and Assistance Publique - Hôpitaux de Paris, among others.

Browse Research Report: http://www.transparencymarketresearch.com/neurofibromatosis-treatment-market.html

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.